Previous 10 | Next 10 |
2023-11-03 03:30:00 ET Summary Following a strong first half of 2023, third quarter returns were more challenged across almost all asset classes. One outlier was high-yield debt, which often serves as a way to de-risk equity exposures when stocks are under pressure. Most year-...
2023-10-26 09:15:02 ET Summary Danaher Corporation, with a focus on biotechnology and life sciences, exhibits strong long-term growth potential, supported by its diverse segments and innovation-driven approach. Danaher's recent financial performance has faced challenges, particula...
2023-10-23 12:05:00 ET Summary U.S. corporate earnings have stagnated with the economy. We stay selective in stocks and harness mega forces like artificial intelligence as key profit centers. The 10-year U.S. Treasury yield hit 16-year highs near 5.0% last week, while U.S. stocks ...
2023-10-19 16:38:44 ET Summary The healthcare sector has underperformed but shows signs of improvement. Non-pharma industries may offer better value in the long term. iShares U.S. Medical Devices ETF offers exposure to popular healthcare names with a diversified portfolio. ...
2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...
2023-10-18 21:49:00 ET Summary After many years of Cumberland’s US Equity ETF portfolios being overweight in the healthcare sector, we are now at our lowest relative market weight for a long time. The economic benefits to the sector from the Covid pandemic are over. The...
2023-10-12 12:05:15 ET Summary FDA announcement of the creation of a Digital Health Advisory Committee causes a 7.2% decline in the iShares U.S. Medical Devices ETF. Digital health industry shows immense potential, driven by consumer-driven healthcare, remote monitoring, and teleh...
2023-10-11 10:59:46 ET More on iShares U.S. Medical Devices ETF IHI: Too Expensive Considering Long-Term Rate Uncertainty JPMorgan says time to buy MedTech based on past Seeking Alpha’s Quant Rating on iShares U.S. Medical Devices ETF Dividend scorecar...
2023-10-10 07:16:00 ET Summary European countries have been plagued by a persistent medicine shortage for the past few years. Supply chain disruptions and increased demand are driving the shortfall. There are potential solutions; and one could involve breeding a whole lot more...
2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Medical Devices Company Name:
IHI Stock Symbol:
NYSE Market:
2024-06-22 11:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-21 21:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 13:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...